Anticancer drugs design, delivery and pharmacology /

Subjects: An electronic book accessible through the World Wide Web; click to view

The chemotherapy source book /

Subjects: “...Cancer Chemotherapy....”
An electronic book accessible through the World Wide Web; click to view

Cancer chemotherapy and biotherapy : principles and practice /

Subjects: “...Cancer Chemotherapy....”
An electronic book accessible through the World Wide Web; click to view

Skin side effects targeted anti-EGFR and anti-BRAF therapies

Subjects: Ligazón do recurso

Novel treatment options in lymphoma and leukemia part 1 of 2 /

Subjects: Ligazón do recurso
Series

Novel treatment options in lymphoma and leukemia part 2 of 2 /

Subjects: Ligazón do recurso
Series

Clinical guide to antineoplastic therapy : a chemotherapy handbook /

Subjects: “...Cancer Chemotherapy Handbooks, manuals, etc....”
An electronic book accessible through the World Wide Web; click to view

Skin side effects targeted anti-EGFR and anti-BRAF therapies

Subjects: Ligazón do recurso

Novel treatment options in lymphoma and leukemia part 1 of 2 /

Subjects: Ligazón do recurso
Series

Novel treatment options in lymphoma and leukemia part 2 of 2 /

Subjects: Ligazón do recurso
Series

Statistical Approaches in Oncology Clinical Development : Current Paradigm and Methodological Advancement /

Subjects: Click here to view

Nanotechnology in cancer and insulin therapy

Subjects: Ligazón do recurso

The evolving role of novel and next generation therapies in the management of multiple myeloma part 1 of 2, introduction and current therapies /

Subjects: Ligazón do recurso

Patient stratification for drug treatment in oncology and other diseases

Subjects: Ligazón do recurso
Series

Drug metabolizing enzymes in cancer therapeutics

Subjects: Ligazón do recurso
Series

Key considerations for cancer pharmacotherapy part 1 of 2 /

Subjects: Ligazón do recurso
Series

Overview of clinical pharmacology in cancer part 1 of 2 /

Subjects: Ligazón do recurso
Series

Functional cancer genomics

Subjects: Ligazón do recurso
Series

Imatinib as a paradigm of targeted cancer therapies

Subjects: “...Chronic myeloid leukemia Chemotherapy....”
Ligazón do recurso
Series (Signal transduction via protein tyrosine kinase receptors)
Series (Small molecule drug discovery)

The evolving role of novel and next generation therapies in the management of multiple myeloma part 1 of 2, introduction and current therapies /

Subjects: Ligazón do recurso